OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
I am an Associate Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School. My lab is focused on statistical genetics approaches to understand the mechanisms of cancer risk, germline-somatic interactions, and response to treatment. We have led the development the Transcriptome-Wide Association (TWAS) and Regulome/Cistrome-Wide Association methodologies to identify cancer risk mechanisms using molecular and epigenetic data. We have also developed multiple methods to infer genetic data from large-scale tumor sequencing and incorporate Real World clinical outcomes for biomarker analyses, including the study of host influences on immunotherapy outcomes. Earlier in my training, I also worked on algorithms to identify genetic relatedness in large data, such as the GERMLINE method for efficient Identity By Descent detection.
